- Home
- AXSM vs ADMA Comparison
AXSM vs ADMA Comparison
Compare AXSM & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- ADMA
- Stock Information
- Founded
- AXSM 2012
- ADMA 2004
- Country
- AXSM United States
- ADMA United States
- Employees
- AXSM N/A
- ADMA N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AXSM Health Care
- ADMA Health Care
- Exchange
- AXSM Nasdaq
- ADMA Nasdaq
- Market Cap
- AXSM 5.1B
- ADMA 5.1B
- IPO Year
- AXSM 2015
- ADMA N/A
- Fundamental
- Price
- AXSM $105.16
- ADMA $19.84
- Analyst Decision
- AXSM Strong Buy
- ADMA Strong Buy
- Analyst Count
- AXSM 15
- ADMA 4
- Target Price
- AXSM $170.20
- ADMA $24.25
- AVG Volume (30 Days)
- AXSM 612.2K
- ADMA 3.4M
- Earning Date
- AXSM 05-05-2025
- ADMA 05-07-2025
- Dividend Yield
- AXSM N/A
- ADMA N/A
- EPS Growth
- AXSM N/A
- ADMA N/A
- EPS
- AXSM N/A
- ADMA 0.84
- Revenue
- AXSM $432,157,000.00
- ADMA $459,381,000.00
- Revenue This Year
- AXSM $63.30
- ADMA $19.45
- Revenue Next Year
- AXSM $61.15
- ADMA $28.10
- P/E Ratio
- AXSM N/A
- ADMA $23.74
- Revenue Growth
- AXSM 72.16
- ADMA 62.23
- 52 Week Low
- AXSM $64.11
- ADMA $9.40
- 52 Week High
- AXSM $139.13
- ADMA $25.67
- Technical
- Relative Strength Index (RSI)
- AXSM 45.61
- ADMA 45.08
- Support Level
- AXSM $101.41
- ADMA $18.95
- Resistance Level
- AXSM $106.77
- ADMA $20.14
- Average True Range (ATR)
- AXSM 3.18
- ADMA 0.78
- MACD
- AXSM -0.23
- ADMA -0.13
- Stochastic Oscillator
- AXSM 39.33
- ADMA 47.59
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.